Federal health officials said Monday they have added new safety warnings to the heart rhythm drug Multaq, after a company study by Sanofi linked the tablet to higher rates of heart attack, stroke and death in a subset of patients.
FDA adds new warning to Sanofi heart medicine
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.